Teaima, M.H.; El-Nadi, M.T.; Hamed, R.R.; El-Nabarawi, M.A.; Abdelmonem, R.
Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats. Pharmaceuticals 2023, 16, 326.
https://doi.org/10.3390/ph16020326
AMA Style
Teaima MH, El-Nadi MT, Hamed RR, El-Nabarawi MA, Abdelmonem R.
Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats. Pharmaceuticals. 2023; 16(2):326.
https://doi.org/10.3390/ph16020326
Chicago/Turabian Style
Teaima, Mahmoud H., Merhan Taha El-Nadi, Raghda Rabe Hamed, Mohamed A. El-Nabarawi, and Rehab Abdelmonem.
2023. "Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats" Pharmaceuticals 16, no. 2: 326.
https://doi.org/10.3390/ph16020326
APA Style
Teaima, M. H., El-Nadi, M. T., Hamed, R. R., El-Nabarawi, M. A., & Abdelmonem, R.
(2023). Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats. Pharmaceuticals, 16(2), 326.
https://doi.org/10.3390/ph16020326